Ricerc@Sapienza

Incidental sonographic discovery of thyroid nodules is an increasingly common event. The vast majority are benign, and those that are malignant are generally associated with an indolent course and low mortality. Sonographic scoring systems have been developed to help clinicians identify nodules that warrant prompt fine-needle aspiration cytology (FNAC), but they are based largely on experience with papillary thyroid cancers. We analyzed the performance of four scoring systems widely used for this purpose (ATA Guidelines, AACE/ACE/AME Guidelines, EU-TIRADS, and K-TIRADS) in patients whose nodules proved to be metastases from other solid cancers. Such nodules reportedly account for 0.2-3% of all thyroid malignancies. Each scoring system was used to retrospectively assess the malignancy risk and indications for FNAC of 5 patients’ thyroid nodules that were ultimately diagnosed as metastases (from renal cell carcinoma, breast cancer, lung cancer in two cases, and esophageal cancer). The primaries identified in these cases are those most commonly reported to metastasize to the thyroid. In two cases, the thyroid metastases were the first sign of undetected neoplastic disease. Although sonography alone cannot distinguish thyroid metastases from primary thyroid malignancies, all four scoring systems classified the metastatic nodules as suspicious enough to require FNAC. The five cases accounted for 0.2% of those cytologically examined in our center. In most cases, cytology provided useful guidance for the subsequent management of these lesions, which differs from that of primary
thyroid cancers and requires multidisciplinary input.